Lorus Therapeutics LORFF LOR Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lorus Therapeutics LORFF LOR

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mark calgary who wrote ()	1/8/2000 3:07:00 PM
From: Frank Moss	of 101

Post from SH: more reasons for higher prices!! An important note on Virulizin - earlier this year, Lorus was invited by the American Association for Cancer Research to present the results of some of their preclinical studies on Virulizin as well as the results from their phase I/II study done in Chicago. The results were presented in an abstract at the AACR's annual conference and were chosen by the AACR from thousands of others as being one of the most exciting new drugs being developed to treat cancer. This news was picked up around the world with articles appearing in major newspapers in Tokyo, New York, Washington, Dallas, Los Angeles and others.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next